China Daily Reads

China Daily Reads

Share this post

China Daily Reads
China Daily Reads
Alibaba, WuXi Biologics lead Hong Kong stock rebound on fund inflows, Fed rate focus

Alibaba, WuXi Biologics lead Hong Kong stock rebound on fund inflows, Fed rate focus

Mainland investors were net buyers of HK$11.6 billion worth of Alibaba shares since it became an eligible component in the Stock Connect scheme this week

Sep 12, 2024
∙ Paid

Share this post

China Daily Reads
China Daily Reads
Alibaba, WuXi Biologics lead Hong Kong stock rebound on fund inflows, Fed rate focus
Share

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Master Leong
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share